Form EFFECT NAVIDEA BIOPHARMACEUTICA
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | May 24, 2022 |
| Accession Number: | 0001437749-22-012862 | ||||||
| Submission Type: | POS AM | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Vistin Pharma ASA: Annual Report 2023
- Porch Group to Release First Quarter 2024 Earnings on May 8, 2024
- Home BancShares, Inc. Announces Second Quarter Cash Dividend
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
